Cargando…

Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting

PURPOSE: Distant metastasis (DM) and neoadjuvant treatment response prediction remain critical challenges in the management of locally advanced rectal cancer (LARC). The aim of this study was to investigate the clinical relevance of viable circulating tumor cells (CTCs) for DM or response in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wen‐Yang, Zhang, Wen, Tang, Yuan, Chen, Si‐Lin, Li, Ning, Lei, Jun‐Qin, Shi, Jin‐Ming, Wang, Shu‐Lian, Li, Ye‐Xiong, Zhang, Kai‐Tai, Jin, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242869/ https://www.ncbi.nlm.nih.gov/pubmed/37014817 http://dx.doi.org/10.1002/cam4.5860

Ejemplares similares

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
por: Liu, Wenyang, et al.
Publicado: (2022)

Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer
por: Wu, Zehua, et al.
Publicado: (2018)

Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis
por: Fadini, Gian Paolo, et al.
Publicado: (2010)

Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients
por: Gwark, Sungchan, et al.
Publicado: (2020)

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection
por: Kim, Honsoul, et al.
Publicado: (2016)

Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma
por: Andreou, D, et al.
Publicado: (2015)

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
por: Chen, Bin, et al.
Publicado: (2021)

Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review
por: Wong, Jolene Si Min, et al.
Publicado: (2020)

Publisher Correction: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients
por: Gwark, Sungchan, et al.
Publicado: (2021)

Anal fistula metastasis of rectal cancer after neoadjuvant therapy: a case report
por: Fukai, Shota, et al.
Publicado: (2022)

Technologies for Viable Circulating Tumor Cell Isolation
por: Tretyakova, Maria S., et al.
Publicado: (2022)

Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells
por: Zhou, Ming-Da, et al.
Publicado: (2014)

Evaluating most probable number method to count and isolate viable methylotrophs
por: Kashyap, S.
Publicado: (2011)

Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
por: Peng, Hai-Hua, et al.
Publicado: (2013)

A Novel, Rapid, and Simple PMA-qPCR Method for Detection and Counting of Viable Brucella Organisms
por: Zhang, Shi-Jun, et al.
Publicado: (2020)

MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer
por: Song, Maxiaowei, et al.
Publicado: (2022)

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
por: Xu, Hongen, et al.
Publicado: (2019)

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
por: Sun, Wenjie, et al.
Publicado: (2016)

Predictive factors for early distant metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Park, Hyojung
Publicado: (2021)

Development and Validation of a Radiomics Model Based on 3-Dimensional Endoanal Rectal Ultrasound of Rectal Cancer for Predicting Lymph Node Metastasis
por: Li, Jin, et al.
Publicado: (2023)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
por: Song, In Hye, et al.
Publicado: (2017)

CORRIGENDUM: Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells
por: Zhou, Ming-Da, et al.
Publicado: (2015)

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
por: Chen, Jia-Yang, et al.
Publicado: (2016)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer
por: Wang, Yipeng, et al.
Publicado: (2018)

MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison
por: Zhang, Zhiwen, et al.
Publicado: (2023)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer
por: Wan, Jue-feng, et al.
Publicado: (2015)

Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Jiang, Ting, et al.
Publicado: (2021)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases
por: Tien, Yu Wen, et al.
Publicado: (2016)

Isothermal microcalorimetry for thermal viable count of microorganisms in pure cultures and stabilized formulations
por: Nykyri, Johanna, et al.
Publicado: (2019)

Validation of three viable-cell counting methods: Manual, semi-automated, and automated
por: Cadena-Herrera, Daniela, et al.
Publicado: (2015)

The Microbial Diversity of Non-Korean Kimchi as Revealed by Viable Counting and Metataxonomic Sequencing
por: Maoloni, Antonietta, et al.
Publicado: (2020)

Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
por: Hsu, Yu-Jen, et al.
Publicado: (2022)

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021)

Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer
por: Chen, Jia-Nan, et al.
Publicado: (2020)

Combination of Direct Viable Count and Fluorescent In Situ Hybridization (DVC-FISH) as a Potential Method for Identifying Viable Vibrio parahaemolyticus in Oysters and Mussels
por: García-Hernández, Jorge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sf9m64sfbuifehq8pjm4t6qpon